The Office of Drug Control (ODC) has issued six infringement notices totalling A$99,000 to Cannatrek for alleged breaches of its medicinal cannabis licence.

The ODC alleged the company failed to meet its obligations under the Narcotic Drugs Act 1967 “to ensure it maintains a system of security at all times at the location where the activities authorised by its licence are undertaken”. 

It added the requirement “helps prevent illegal or unauthorised removal of cannabis plants or cannabis drugs”.   

The fines relate to alleged breaches at Cannatrek’s Queensland facility.

The ODC said licence holders must understand and comply with their responsibilities under the act and all licence conditions. As well as financial penalties, non-compliance could also result in civil or criminal proceedings.

Cannatrek told Cannabiz in a statement: “The infringement notices relate to an incident which occurred at Cannatrek’s cultivation site where it was targeted by criminal activity.” 

The firm, which has held a medicinal cannabis licence at the site since 2018, said the incident was the first of its kind.

It added: “Cannatrek takes these allegations seriously and has conducted a comprehensive review of its security infrastructure and procedures at the site. 

“[We] respect the decision and will proactively work with the ODC to develop measures to counter organised crime across the medicinal cannabis industry in Australia.

“As this incident remains the subject of an ongoing investigation by Queensland Police, Cannatrek is not in a position to make any further comment at this time.”

Prior to launching Cannabiz, Martin was co-founder and CEO of Asia-Pac’s leading B2B media and marketing information brand Mumbrella, overseeing its sale to Diversified Communications in 2017. A journalist...

Leave a comment